Companies / Sage Therapeutics, Inc.
Sage Therapeutics, Inc.
SAGECIK 1597553
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 16, 2015 | Jonas Jeffrey M Executive | Sell Open-market sale | Common Stock | $4.94M | -65K -64.79% | 35,303 | medium |
| Jun 15, 2015 | Jonas Jeffrey M Executive | Sell Open-market sale | Common Stock | $4.92M | -62K -78.26% | 17,329 | medium |
| Jun 16, 2015 | Jonas Jeffrey M Executive | Sell Open-market sale | Common Stock | $2.21M | -29K -83.00% | 6,000 | medium |
| Jun 16, 2015 | Jonas Jeffrey M Executive | Sell Open-market sale | Common Stock | $1.09M | -14K -12.36% | 100,276 | medium |
| Aug 5, 2021 | Greene Barry E CEO | Buy Open-market buy | Common Stock | $1.02M | +24K +268.64% | 32,440 | high |
| Jun 16, 2021 | Starr Kevin P Director | Buy Open-market buy | Common Stock | $1000.0K | +18K +5.89% | 320,659 | high |
| Jun 15, 2015 | Jonas Jeffrey M Executive | Sell Open-market sale | Common Stock | $886.2K | -11K -65.38% | 6,000 | medium |
| Jun 16, 2015 | Jonas Jeffrey M Executive | Sell Open-market sale | Common Stock | $531.6K | -7K -5.61% | 114,422 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SAGE | common | 78667J108 |